Methodology of Citrate-based Biomaterial Design for Tissue Engineering, Drug Delivery, and Bioimaging

Jian Yang, Associate Professor of Bioengineering, The University of Texas at Arlington

Friday, April 6, 2012, 3:30pm

Spanos Auditorium

This seminar is part of the Jones Seminars on Science, Technology, and Society series.

Biomaterials are critical components of biomedical devices and products. A novel biomaterial may create new fields of studies and opportunities to tackle unmet clinical problems. In this seminar, Dr. Yang will discuss a methodology of citrate-based biomaterial design for tissue engineering, drug delivery, and bioimaging. This methodology allows innovative developments of a family of biodegradable polymers (PNAS 2009,106,10086; Biomaterials 2008,29,4637; Soft Matter 2010,6,2449; Biomaterials 2010,31,9092) in Dr. Yang's lab to address the critical needs for versatile biomaterials in biomedical engineering. Based on these new biomaterials, specific applications to be covered in this seminar include new scaffolding strategy for cardiovascular tissue engineering, micro/nano-composites for orthopedic devices and bone regeneration, bioinspired adhesives for wound healing, biodegradable stent for atherosclerosis, cellular and tissue bioimaging, and theranostic nanoparticles for cancer diagnosis and treatment.

About the Speaker

Dr. Jian Yang received his Ph.D. degree in 2002, emphasized on Polymeric Biomaterials at The Chinese Academy of Sciences in Beijing. He then joined the Department of Biomedical Engineering at Northwestern University at Evanston, IL for his postdoctoral training. Dr. Yang became assistant professor in the Department of Bioengineering at University of Texas at Arlington in 2006 and was promoted to associate professor in 2011. Dr Yang has published 50 peer-reviewed journal articles, 14 patents/patent applications, 3 book chapters, and more than 90 conference abstracts/presentations. Dr. Yang's research has been funded by major funding agencies including the National Science Foundation (NSF), the National Institutes of Health (NIH), and the American Heart Association (AHA). Dr. Yang serves as a reviewer for more than 30 journals. He is also a frequent grant reviewer for NIH, NSF, AHA, and other federal and private funding agencies. Dr. Yang is currently mentoring 1 research associate, 3 postdoctoral fellows, 6 Ph.D. students, 3 M.S. students, and a number of undergraduate/high school students to conduct his research in biomaterials, tissue engineering, cancer drug delivery and imaging, and medical devices.